Nufarm Limited
Nufarm Limited (NUFMF) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Nufarm Limited (NUFMF), featuring income statements, balance sheets, and cash flow data.
Nufarm Limited (NUFMF) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Nufarm Limited NUFMF financial performance.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $793.93M | $793.93M | $879.02M | $879.02M |
| Cost of Revenue | $610.77M | $610.77M | $638.29M | $638.29M |
| Gross Profit | $183.16M | $183.16M | $240.73M | $240.73M |
| Gross Profit Ratio | $0.23 | $0.23 | $0.27 | $0.27 |
| R&D Expenses | $32.15M | $46.29M | $11.17M | $11.17M |
| SG&A Expenses | $187.19M | $187.19M | $183.74M | $183.74M |
| Operating Expenses | $197.15M | $197.15M | $194.37M | $195.67M |
| Total Costs & Expenses | $807.92M | $807.92M | $832.66M | $833.96M |
| Interest Income | $0.00 | $0.00 | $2.81M | $25.22M |
| Interest Expense | $0.00 | $0.00 | $46.99M | $0.00 |
| Depreciation & Amortization | $9.45M | $9.45M | $49.005M | $49.005M |
| EBITDA | -$7.48M | -$7.48M | $95.97M | $95.97M |
| EBITDA Ratio | -$0.009 | -$0.009 | $0.11 | $0.11 |
| Operating Income | -$13.99M | -$13.99M | $46.36M | $46.97M |
| Operating Income Ratio | -$0.02 | -$0.02 | $0.05 | $0.05 |
| Other Income/Expenses (Net) | -$28.48M | -$28.48M | -$26.52M | -$27.13M |
| Income Before Tax | -$42.47M | -$42.47M | $19.84M | $19.84M |
| Income Before Tax Ratio | -$0.05 | -$0.05 | $0.02 | $0.02 |
| Income Tax Expense | -$30.17M | $15.09M | $4.74M | $4.74M |
| Net Income | -$27.38M | -$27.38M | $24.58M | $19.74M |
| Net Income Ratio | -$0.03 | -$0.03 | $0.03 | $0.02 |
| EPS | -$0.10 | -$0.10 | $0.04 | $0.05 |
| Diluted EPS | -$0.09 | -$0.09 | $0.05 | $0.05 |
| Weighted Avg Shares Outstanding | $382.31M | $318.95M | $477.33M | $383.25M |
| Weighted Avg Shares Outstanding (Diluted) | $382.31M | $382.25M | $384.96M | $384.96M |
Financial performance has remained strong, with revenue growing from $879.02M in Q1 2024 to $793.93M in Q4 2024. Gross profit continued to perform well, with margins at 23% in the latest quarter. Operating income reached -$13.99M in Q4 2024, holding a steady -2% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at -$7.48M. Net income rose to -$27.38M, keeping EPS at -$0.10. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan